People living with a serious chronic disease are experts by experience. By sharing their experience, they help us improve the future of healthcare.
More than 25,000 people participate in our clinical trials each year. They are one of the most important steps to finding new medicines.
Look at our future science
Review our clinical pipeline
What is a clinical trial and how to participate
We believe that a healthy environment, society and economy are fundamental to long-term business success, and we will play our part, also on the long-term.
Find answers to some of the more frequently asked questions on sustainability and responsible business practices.
Explore features and points of view from
Novo Nordisk and the society we serve
Anette is an operator at Novo Nordisk
A note from our CEO, Lars Fruergaard Jørgensen on how we are contributing to the fight against COVID-19 whilst delivering on our responsibilities to people living with diabetes and other serious chronic diseases
Read our response
Abigail is living with obesity
In a series of intimate portraits, photographer Abbie Trayler-Smith puts a lens on the stories and struggles of people living with obesity.
See the portraits
Head of type 1 diabetes, immunology and kidney disease
Novo Nordisk Research Centre Seattle
At Novo Nordisk, we’re working hard to find new therapies that can delay, prevent and even cure type 1 diabetes.
Here’s how far we’ve come
Could digital health tools provide the solution to China’s burgeoning diabetes crisis? Our CEO Lars Fruergaard Jørgensen believes so.
Find out why here
What if medicines injected by millions could be delivered in tablets?
Our CSO Mads Krogsgaard Thomsen looks to the future
Our head of obesity research, Mads Tang-Christensen, explains the brain’s role in the struggle to lose weight.
Read the story
Jacob Sten Petersen is working to cure type 1 diabetes, a disease his five-year-old daughter Vita lives with.
Hear their story
Photographer Jesper Westley captures the many faces of the global diabetes pandemic.